Oxbow Advisors LLC Has $11.47 Million Position in Nutrien Ltd. $NTR

Oxbow Advisors LLC raised its stake in Nutrien Ltd. (NYSE:NTR) by 6.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 152,059 shares of the company’s stock after buying an additional 9,078 shares during the period. Nutrien comprises about 1.0% of Oxbow Advisors LLC’s portfolio, making the stock its 22nd biggest position. Oxbow Advisors LLC’s holdings in Nutrien were worth $11,474,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in NTR. Lesa Sroufe & Co lifted its stake in shares of Nutrien by 1.8% in the first quarter. Lesa Sroufe & Co now owns 52,002 shares of the company’s stock worth $3,924,000 after acquiring an additional 921 shares during the period. HB Wealth Management LLC increased its position in Nutrien by 12.9% during the 1st quarter. HB Wealth Management LLC now owns 4,477 shares of the company’s stock valued at $337,000 after purchasing an additional 511 shares during the period. Moran Wealth Management LLC increased its position in Nutrien by 28.8% during the 1st quarter. Moran Wealth Management LLC now owns 33,383 shares of the company’s stock valued at $2,512,000 after purchasing an additional 7,462 shares during the period. PFG Investments LLC increased its position in Nutrien by 36.7% during the 1st quarter. PFG Investments LLC now owns 12,395 shares of the company’s stock valued at $935,000 after purchasing an additional 3,325 shares during the period. Finally, World Investment Advisors raised its holdings in Nutrien by 11.9% during the 1st quarter. World Investment Advisors now owns 5,586 shares of the company’s stock worth $421,000 after purchasing an additional 595 shares during the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

Nutrien Price Performance

Shares of NTR opened at $65.04 on Friday. Nutrien Ltd. has a 52-week low of $53.03 and a 52-week high of $85.36. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. The business’s 50 day moving average price is $68.12 and its two-hundred day moving average price is $69.58. The firm has a market cap of $31.17 billion, a PE ratio of 13.25, a price-to-earnings-growth ratio of 0.60 and a beta of 0.62.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company’s revenue for the quarter was up 18.5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.11 EPS. On average, equities analysts anticipate that Nutrien Ltd. will post 5.45 EPS for the current year.

Nutrien Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.55 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.20 annualized dividend and a yield of 3.4%. Nutrien’s dividend payout ratio is currently 44.81%.

Wall Street Analysts Forecast Growth

NTR has been the topic of a number of recent analyst reports. UBS Group dropped their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research report on Monday, May 11th. Wall Street Zen cut shares of Nutrien from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Wells Fargo & Company raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $77.00 to $100.00 in a research note on Friday, March 13th. Morgan Stanley boosted their target price on shares of Nutrien from $77.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, April 8th. Finally, BMO Capital Markets upped their price target on shares of Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, March 18th. Thirteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $81.61.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.